RecruitingNCT03138941

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Studying Autosomal systemic lupus erythematosus

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Monash University
Principal Investigator
Eric Morand
Monash University
Enrollment
5000 enrolled
Eligibility
18 years · All sexes
Timeline
20132032

Study locations (20)

Collaborators

Flinders Medical Centre, Adelaide, AUSTRALIA · St. Vincent's Hospital, Melbourne, AUSTRALIA · Royal Adelaide Hospital, Adelaide, AUSTRALIA · The University of New South Wales · People's Hospital, Peking University Health Science Center, Beijing, CHINA · Peking University First Hospital, Beijing, CHINA · The University of Hong Kong · University of Padjadjaran, Bandung, INDONESIA · Tokyo Women's Medical University, JAPAN · University of Occupational and Environmental Health, JAPAN · Keio University, JAPAN · Hanyang University Hospital for Rheumatic Diseases, REPUBLIC OF KOREA · University of Santo Tomas Hospital, Philippines · National University Hospital, Singapore · Tan Tock Seng Hospital · Chang Gung Memorial Hospital · Taichung Veterans General Hospital · Chiang Mai University Hospital, THAILAND · Middlemore Hospital, New Zealand · North Shore Hospital, Auckland, NEW ZEALAND · Auckland District Health Board, Auckland, NEW ZEALAND · Teaching Hospital Kandy, SRI LANKA · University of the Philippines, Philippines

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03138941 on ClinicalTrials.gov

Other trials for Autosomal systemic lupus erythematosus

Additional recruiting or active studies for the same condition.

See all trials for Autosomal systemic lupus erythematosus

← Back to all trials